Milestone Pharmaceuticals Inc.
MIST· Nasdaq
MISTMilestone Pharmaceuticals Inc.
Filed May 14, 2020 · 10-Q · 44 days after period end · 0001558370-20-006548
| Metric | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|
| Net Income | -$16.34M | -$10.45M | -$4.18M |
| EPS Diluted | -$0.67 | -$17.32 | -$15.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 14, 2020 · 44 d after period end
